Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice

Agustina Roldan-Deamicis1, Eliana Alonso2, Belén Brie1

  • 1Instituto de Investigaciones Biomédicas, Facultad de Ciencias Medicas, Pontificia Universidad Católica Argentina - UCA - CONICET, Buenos Aires, Argentina.

Cancer Medicine
|July 13, 2016
PubMed

Insights

Maitake D-Fraction Pro4X significantly blocked over 60% of breast cancer development in mice. This mushroom extract also reduced tumor invasiveness, angiogenesis, and improved survival, offering potential for breast cancer prevention.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Tumor microenvironment's role in immune tolerance is crucial for cancer development and immunotherapy.
  • Targeted therapies aim to destroy cancer cells selectively, sparing normal cells.
  • Maitake mushroom extract (D-Fraction), rich in β-glucans, shows potential immune-modulating and anti-tumoral effects.

Purpose of the Study:

  • To investigate the efficacy of Maitake D-Fraction Pro4X in preventing breast cancer.
  • To elucidate the molecular mechanisms underlying Maitake D-Fraction's anti-cancer effects.
  • To evaluate Maitake D-Fraction's impact on tumor invasiveness, angiogenesis, and survival.

Main Methods:

  • Female BALBc mice were treated with Maitake D-Fraction Pro4X or Maitake Standard.
  • Mammary tumorigenesis was induced by implanting LM3 tumor cells.
  • Cancer prevention, tumor growth, survival rates, and histological/genetic analyses were assessed.

Main Results:

  • Maitake D-Fraction Pro4X blocked over 60% of breast cancer development.
  • Maitake Standard showed 26% oncogenesis prevention compared to controls.
  • Maitake D-Fraction Pro4X reduced tumor invasiveness and angiogenesis, and increased overall survival.

Conclusions:

  • Maitake D-Fraction Pro4X demonstrates significant potential in preventing breast cancer development in a mouse model.
  • The extract effectively inhibits tumor invasiveness and angiogenesis.
  • Further research into Maitake D-Fraction's molecular mechanisms could lead to novel breast cancer therapies.